Page 1163 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 64 Pathobiology of Acute Lymphoblastic Leukemia 1019.e3

92. Bain G, Engel I, Robanus Maandag EC, et al: E2A deficiency leads to 114. Dear TN, Sanchez-Garcia I, Rabbitts TH: The HOX11 gene encodes
abnormalities in alphabeta T-cell development and to rapid develop- a DNA-binding nuclear transcription factor belonging to a distinct
ment of T-cell lymphomas. Mol Cell Biol 17(8):4782–4791, 1997. family of homeobox genes. Proc Natl Acad Sci USA 90(10):4431–4435,
93. Yan W, Young AZ, Soares VC, et al: High incidence of T-cell tumors 1993.
in E2A-null mice and E2A/Id1 double-knockout mice. Mol Cell Biol 115. Kennedy MA, Gonzalez-Sarmiento R, Kees UR, et al: HOX11, a
17(12):7317–7327, 1997. homeobox-containing T-cell oncogene on human chromosome 10q24.
94. Keeshan K, He Y, Wouters BJ, et al: Tribbles homolog 2 inactivates Proc Natl Acad Sci USA 88(20):8900–8904, 1991.
C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell 116. Lu M, Gong ZY, Shen WF, et al: The tcl-3 proto-oncogene altered by
10(5):401–411, 2006. chromosomal translocation in T-cell leukemia codes for a homeobox
95. Mansour MR, Sanda T, Lawton LN, et al: The TAL1 complex targets protein. EMBO J 10(10):2905–2910, 1991.
the FBXW7 tumor suppressor by activating miR-223 in human T cell 117. Dube ID, Kamel-Reid S, Yuan CC, et al: A novel human homeobox
acute lymphoblastic leukemia. J Exp Med 210(8):1545–1557, 2013. gene lies at the chromosome 10 breakpoint in lymphoid neoplasias
96. McGuire EA, Hockett RD, Pollock KM, et al: The t(11;14)(p15;q11) with chromosomal translocation t(10;14). Blood 78(11):2996–3003,
in a T-cell acute lymphoblastic leukemia cell line activates multiple 1991.
transcripts, including Ttg-1, a gene encoding a potential zinc finger 118. Ferrando AA, Look AT: Gene expression profiling in T-cell acute
protein. Mol Cell Biol 9(5):2124–2132, 1989. lymphoblastic leukemia. Semin Hematol 40(4):274–280, 2003.
97. Boehm T, Foroni L, Kaneko Y, et al: The rhombotin family of cysteine- 119. Kees UR, Heerema NA, Kumar R, et al: Expression of HOX11 in
rich LIM-domain oncogenes: distinct members are involved in T-cell childhood T-lineage acute lymphoblastic leukaemia can occur in the
translocations to human chromosomes 11p15 and 11p13. Proc Natl absence of cytogenetic aberration at 10q24: a study from the Children’s
Acad Sci USA 88(10):4367–4371, 1991. Cancer Group (CCG). Leukemia 17(5):887–893, 2003.
98. Royer-Pokora B, Loos U, Ludwig WD: TTG-2, a new gene encoding a 120. Berger R, Dastugue N, Busson M, et al: t(5;14)/HOX11L2-positive
cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell T-cell acute lymphoblastic leukemia. A collaborative study of the
leukaemia with the t(11;14)(p13;q11). Oncogene 6(10):1887–1893, Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia
1991. 17(9):1851–1857, 2003.
99. Wadman I, Li J, Bash RO, et al: Specific in vivo association between 121. Bernard OA, Busson-LeConiat M, Ballerini P, et al: A new recurrent
the bHLH and LIM proteins implicated in human T cell leukemia. and specific cryptic translocation, t(5;14)(q35;q32), is associated with
EMBO J 13(20):4831–4839, 1994. expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
100. Valge-Archer VE, Osada H, Warren AJ, et al: The LIM protein RBTN2 Leukemia 15(10):1495–1504, 2001.
and the basic helix-loop-helix protein TAL1 are present in a complex 122. Ballerini P, Blaise A, Busson-Le Coniat M, et al: HOX11L2 expres-
in erythroid cells. Proc Natl Acad Sci USA 91(18):8617–8621, 1994. sion defines a clinical subtype of pediatric T-ALL associated with poor
101. Larson RC, Lavenir I, Larson TA, et al: Protein dimerization between prognosis. Blood 100(3):991–997, 2002.
Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates 123. Mauvieux L, Leymarie V, Helias C, et al: High incidence of Hox11L2
T cell tumorigenesis in transgenic mice. EMBO J 15(5):1021–1027, expression in children with T-ALL. Leukemia 16(12):2417–2422,
1996. 2002.
102. Porcher C, Swat W, Rockwell K, et al: The T cell leukemia oncoprotein 124. Cave H, Suciu S, Preudhomme C, et al: Clinical significance of
SCL/tal-1 is essential for development of all hematopoietic lineages. Cell HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11
86(1):47–57, 1996. expression, and of SIL-TAL fusion in childhood T-cell malignancies:
103. Lahlil R, Lecuyer E, Herblot S, et al: SCL assembles a multifacto- results of EORTC studies 58881 and 58951. Blood 103(2):442–450,
rial complex that determines glycophorin A expression. Mol Cell Biol 2004.
24(4):1439–1452, 2004. 125. von Boehmer H, Aifantis I, Azogui O, et al: Crucial function of the
104. Warren AJ, Colledge WH, Carlton MB, et al: The oncogenic cysteine- pre-T-cell receptor (TCR) in TCR beta selection, TCR beta allelic
rich LIM domain protein rbtn2 is essential for erythroid development. exclusion and alpha beta versus gamma delta lineage commitment.
Cell 78(1):45–57, 1994. Immunol Rev 165:111–119, 1998.
105. Osada H, Grutz GG, Axelson H, et al: LIM-only protein Lmo2 forms a 126. Dadi S, Le Noir S, Payet-Bornet D, et al: TLX homeodomain
protein complex with erythroid transcription factor GATA-1. Leukemia oncogenes mediate T cell maturation arrest in T-ALL via interaction
11(Suppl 3):307–312, 1997. with ETS1 and suppression of TCRalpha gene expression. Cancer Cell
106. McGuire EA, Rintoul CE, Sclar GM, et al: Thymic overexpression of 21(4):563–576, 2012.
Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/ 127. De Keersmaecker K, Real PJ, Gatta GD, et al: The TLX1 oncogene
lymphoma. Mol Cell Biol 12(9):4186–4196, 1992. drives aneuploidy in T cell transformation. Nat Med 16(11):1321–1327,
107. Fisch P, Boehm T, Lavenir I, et al: T-cell acute lymphoblastic lymphoma 2010.
induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain 128. Kawabe T, Muslin AJ, Korsmeyer SJ: HOX11 interacts with protein
genes. Oncogene 7(12):2389–2397, 1992. phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpoint.
108. Larson RC, Fisch P, Larson TA, et al: T cell tumours of disparate Nature 385(6615):454–458, 1997.
phenotype in mice transgenic for Rbtn-2. Oncogene 9(12):3675–3681, 129. Della Gatta G, Palomero T, Perez-Garcia A, et al: Reverse engineering
1994. of TLX oncogenic transcriptional networks identifies RUNX1 as tumor
109. Larson RC, Osada H, Larson TA, et al: The oncogenic LIM protein suppressor in T-ALL. Nat Med 18(3):436–440, 2012.
Rbtn2 causes thymic developmental aberrations that precede malig- 130. Speleman F, Cauwelier B, Dastugue N, et al: A new recurrent inversion,
nancy in transgenic mice. Oncogene 11(5):853–862, 1995. inv(7)(p15q34), leads to transcriptional activation of HOXA10 and
110. Neale GA, Rehg JE, Goorha RM: Ectopic expression of rhombotin-2 HOXA11 in a subset of T-cell acute lymphoblastic leukemias. Leukemia
causes selective expansion of CD4-CD8- lymphocytes in the thymus 19(3):358–366, 2005.
and T-cell tumors in transgenic mice. Blood 86(8):3060–3071, 131. Soulier J, Clappier E, Cayuela JM, et al: HOXA genes are included in
1995. genetic and biologic networks defining human acute T-cell leukemia
111. Shirasawa S, Yunker AM, Roth KA, et al: Enx (Hox11L1)-deficient (T-ALL). Blood 106(1):274–286, 2005.
mice develop myenteric neuronal hyperplasia and megacolon. Nat Med 132. Cauwelier B, Cave H, Gervais C, et al: Clinical, cytogenetic and molec-
3(6):646–650, 1997. ular characteristics of 14 T-ALL patients carrying the TCRbeta-HOXA
112. Dear TN, Colledge WH, Carlton MB, et al: The Hox11 gene is rearrangement: a study of the Groupe Francophone de Cytogenetique
essential for cell survival during spleen development. Development Hematologique. Leukemia 21(1):121–128, 2007.
121(9):2909–2915, 1995. 133. Kamps MP, Look AT, Baltimore D: The human t(1;19) translocation in
113. Roberts CW, Shutter JR, Korsmeyer SJ: Hox11 controls the genesis of pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with
the spleen. Nature 368(6473):747–749, 1994. differing transforming potentials. Genes Dev 5(3):358–368, 1991.